|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2005-05-26 Sale |
2005-05-27 11:52 am | ENCYSIVE PHARMACEUTICALS INC | ENCY | MAETZOLD DEREK J (V.P., Marketing & Sales) | 1,800 | $10.48 | $18,864 | 27,988 (Direct) | View |
| Transaction & Date |
Reported Date |
Company | Symbol | Insider Relationship | Shares Traded | Average Price |
Total Amount |
Shares Ownership |
Filing |
| 2008-04-01 Equity Swap |
2008-04-03 6:17 pm | ENCYSIVE PHARMACEUTICALS INC | ENCY | MAETZOLD DEREK J (V.P., Marketing & Sales) | 172,895 | $2.35 | $406,303 | 0 (Direct) |
View |
| 2007-12-11 Option Award(A) | 2008-01-15 6:26 pm |
ENCYSIVE PHARMACEUTICALS INC | ENCY | MAETZOLD DEREK J (V.P., Marketing & Sales) | 100,000 | $0 | $0 | 172,895 (Direct) | View |
| 2007-12-11 Option Award | 2007-12-13 5:50 pm | ENCYSIVE PHARMACEUTICALS INC | ENCY | MAETZOLD DEREK J (V.P., Marketing & Sales) | 50,000 | $0 | $0 | 122,895 (Direct) |
View |
| 2007-03-14 Option Award |
2007-03-16 8:15 pm | ENCYSIVE PHARMACEUTICALS INC | ENCY | MAETZOLD DEREK J (V.P., Marketing & Sales) | 30,218 | $0 | $0 | 72,895 (Direct) | View |
| 2006-03-02 Option Award | 2006-03-03 7:06 pm |
ENCYSIVE PHARMACEUTICALS INC | ENCY | MAETZOLD DEREK J (V.P., Marketing & Sales) | 14,689 | $0 | $0 | 42,677 (Direct) | View |
| 2005-03-01 Option Award | 2005-03-03 2:03 pm | ENCYSIVE PHARMACEUTICALS INC | ENCY | MAETZOLD DEREK J (V.P., Marketing & Sales) | 2,419 | $0 | $0 | 29,788 (Direct) | View |
| 2004-03-04 Option Award | 2004-03-05 6:25 pm | ENCYSIVE PHARMACEUTICALS INC | ENCY | MAETZOLD DEREK J (V.P., Marketing & Sales) | 2,369 | $0 | $0 | 27,369 (Direct) |
View |
| Transaction & Date | Reported Date |
Exercisable Expiration |
Company | Symbol | Insider Relationship |
Shares Traded | Conversion Price |
Shares Ownership |
Filing |
| 2007-12-11 Option Award |
2007-12-13 5:50 pm |
N/A 2017-12-11 |
ENCYSIVE PHARMACEUTICALS INC | ENCY | MAETZOLD DEREK J (V.P., Marketing & Sales) | 25,000 | $0.78 | 25,000 (Direct) | View |
| 2007-12-11 Option Award |
2007-12-13 5:50 pm | N/A 2017-12-11 |
ENCYSIVE PHARMACEUTICALS INC | ENCY | MAETZOLD DEREK J (V.P., Marketing & Sales) | 25,000 | $0.78 | 25,000 (Direct) | View |
| 2007-03-14 Option Award | 2007-03-16 8:15 pm |
N/A 2017-03-14 |
ENCYSIVE PHARMACEUTICALS INC | ENCY | MAETZOLD DEREK J (V.P., Marketing & Sales) | 22,855 | $2.995 | 22,855 (Direct) |
View |
| 2007-03-14 Option Award |
2007-03-16 8:15 pm | N/A 2017-03-14 |
ENCYSIVE PHARMACEUTICALS INC | ENCY | MAETZOLD DEREK J (V.P., Marketing & Sales) | 22,853 | $2.995 | 22,853 (Direct) |
View |
| 2006-03-02 Option Award |
2006-03-03 7:06 pm | N/A 2016-03-02 | ENCYSIVE PHARMACEUTICALS INC | ENCY | MAETZOLD DEREK J (V.P., Marketing & Sales) | 27,837 | $8.85 | 27,837 (Direct) | View |
| 2005-03-01 Option Award | 2005-03-03 2:03 pm | N/A 2015-03-01 | ENCYSIVE PHARMACEUTICALS INC | ENCY | MAETZOLD DEREK J (V.P., Marketing & Sales) | 27,222 | $11.02 | 27,222 (Direct) |
View |
| 2005-03-01 Option Award |
2005-03-03 2:03 pm | N/A 2015-03-01 | ENCYSIVE PHARMACEUTICALS INC | ENCY | MAETZOLD DEREK J (V.P., Marketing & Sales) | 6,778 | $11.02 | 6,778 (Direct) |
View |
| 2004-03-04 Option Award |
2004-03-05 6:25 pm | N/A 2014-03-04 |
ENCYSIVE PHARMACEUTICALS INC | ENCY | MAETZOLD DEREK J (V.P., Marketing & Sales) | 30,000 | $9.85 | 30,000 (Direct) | View |
|
© 2005-2008 SecForm4.Com All rights reserved. Archives: 2008 2007 2006 2005 2004 2003 Fri, 05 Dec 2008 04:07:27 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |